Fate Therapeutics Q3 Results Expected October 29
Fate Therapeutics is scheduled to report Q3'26 results on October 29; the time is unspecified. Revenue is estimated at 1.14 million USD and EPS at (0.27) USD.
FATE (Fate Therapeutics, Inc.) is set to announce its Q3'26 results on October 29, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 1.14 million USD with EPS (earnings per share) anticipated at (0.27) USD. Learn more details a…